MingSight Pharmaceuticals Pty Limited Report issue

For profit Phase 1 Phase 2
Founded: San Diego California United States (2009)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2015
NCT02406989
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

MingSight Pharmaceuticals, Inc | MingSight Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

ms-553 (2 trials)

Drugs in Phase 1 Trials (1)

ms-533 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Lymphoid (Phase 1)

Lymphoma (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2